Unichem Laboratories Limited has informed the Exchange regarding 'USFDA Inspection Report For Pithampur API Plant'.
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unichem Laboratories has received the Establishment Inspection Report (EIR) from the USFDA for its Pithampur API facility, which was inspected from February 24 to 28, 2025. The USFDA has classified the inspection as Voluntary Action Initiated (VAI), indicating that any observations made do not require official regulatory action. This is a follow-up to the company's earlier communication on March 1, 2025 about the inspection. VAI is one of the better classifications under the USFDA's inspection rating system and signals that no serious compliance issues were found.
This is a positive outcome for Unichem Labs as it clears regulatory uncertainty around the Pithampur API plant, which can continue supplying the US market without restrictions. Shareholders can view this as a relief, though the company may still need to voluntarily address minor observations flagged by the FDA.